Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Trading Day Couldn’t End Early Enough For These 4 Stocks

Page 1 of 2

Platform Specialty Products Corp. (NYSE:PAH), Baozun Inc. (NASDAQ:BZUN), Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) and NetEase Inc. (NASDAQ:NTES) began and ended the day in red territory on a shortened trading day on Friday, following various headlines including insider trading, earnings results, a regulatory violation, and an analyst initiating coverage. We’ll consider how these stocks are being traded among top hedge funds in addition to studying the recent negative catalysts to see if we can expect the companies to overcome them.

In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, Insider Monkey looks at only the aristocrats of this group, around 730 funds. Contrary to popular belief, Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge, not because they are not good at picking stocks on the long side of their portfolios. Hedge funds did in fact manage to outperform the market on the long side of their portfolios. In fact, the 15 most popular small-cap stocks among hedge funds has returned 102% since the end of August 2012, beat the S&P 500 Index by 53 percentage points (see the details here).

Platform Specialty Products Corp. (NYSE:PAH) lost 4.86% today, a few days after its top executives bought shares in the company, which sent shares soaring. Platform Specialty Products Corp. (NYSE:PAH) Chairman Martin Franklin, its COO Benjamin Gliklich, and its CFO Sanjiv Khattri bought approximately 1 million shares, with Franklin and Berggruen Holdings buying 500,000 shares apiece, news which was announced on Monday. The executives expressed confidence in their business and its ability to generate free cash flow, which prompted the purchase. Shares are down by 47% this year.

Out of 730 hedge funds which Insider Monkey follows, 40 funds held $1.38 billion worth of shares of Platform Specialty Products, or 51.80% of the company’s outstanding stock. Pershing Square, headed by top investor Bill Ackman, holds 42.74 million shares of the company, which are valued at $540.63 million.

Follow Platform Specialty Products Corp (NYSE:PAH)
Trade (NYSE:PAH) Now!

Baozun Inc. (NASDAQ:BZUN) dropped 7.47% following the release of its third-quarter 2015 results, despite a greater than 57% increase in total net revenue. Baozun Inc. (NASDAQ:BZUN) reported total net revenue of RMB587.6 million, or US$92.5 million. It also booked net income of RMB72.4 million, or US$1.1 million, which swung the company into positive territory after reporting a net loss in the prior-year period.

“We are pleased with another quarter of robust financial and operational results, mainly driven by strong growth from our existing online stores and the expansion and optimization of our portfolio of brand partners,” Baozun Chairman and CEO Vincent Qiu said. “The number of our brand partners increased by 10 during the quarter to 109.”

Through the end of September, five funds in our database held 2.50% of the company’s outstanding stock.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!